Outset Medical (OM) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
4 Jun, 2026Opening remarks and agenda
Chair and CEO welcomed stockholders, introduced board members, CFO, and independent auditor present at the meeting.
Inspector of Election and proxy service provider were introduced, and the agenda was posted on the virtual meeting website.
Shareholder proposals
Three formal items were considered: election of two Class III directors, advisory vote on 2025 executive compensation, and ratification of the independent auditor for 2026.
Overview of voting outcomes
Both director nominees were elected to serve until the 2029 annual meeting.
Advisory approval of 2025 executive compensation passed.
Ratification of KPMG LLP as independent auditor for 2026 was approved.
Official voting results will be filed on Form 8-K with the SEC within four business days.
Latest events from Outset Medical
- Next-gen Tablo launch and console refresh cycle set to drive growth and profitability in 2026.OM
RBC Capital Markets Global Healthcare Conference 202619 May 2026 - Q1 revenue fell 6% but gross margin hit 43.4% and net loss narrowed to $19.0 million.OM
Q1 20268 May 2026 - Votes will be held on director elections, executive pay, and auditor ratification for 2026.OM
Proxy filing24 Apr 2026 - Annual meeting covers director elections, say-on-pay, auditor ratification, and governance updates.OM
Proxy filing24 Apr 2026 - 2025 revenue rose 5% to $119.5M, margins improved, and 2026 growth is guided at 5–9%.OM
Q4 202511 Feb 2026 - Revenue declined but gross margin and recurring revenue improved; 2024 outlook lowered.OM
Q2 20242 Feb 2026 - Cost reductions and margin expansion accelerate profitability as TabloCart ramps post-clearance.OM
Goldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026 - Q3 2024 saw record recurring revenue, margin gains, and raised guidance despite ongoing restructuring.OM
Q3 202416 Jan 2026 - Innovative dialysis solutions and strong recurring revenue drive growth and industry disruption.OM
44th Annual J.P. Morgan Healthcare Conference15 Jan 2026